Featured insights The latest at the Foundation Insights from our industry-shifting research and analysis, coverage in the international media, events, and all the latest from the Access to Medicine Foundation. Research Is the industry making progress on improving access to medicine? 18 November 2022 Research What are pharma companies doing to expand access to insulin – and how can efforts be scaled up? 06 October 2022 News Index finds more pharma companies moving to address access to medicine. Will they now go further? 15 November 2022 Featured News Gas companies took action during COVID-19. Now they must expand access to medical oxygen over the long term. 18 April 2023 Resource Center Explore our research reports and publications Featured News First-of-its-kind framework to assess how generics manufacturers expand access to medicine 15 February 2023 News New Supervisory Board members Linda-Gail Bekker and Mariângela Simão bring a world of experience 01 June 2023 Research Lack of access to antibiotics and antifungals compromise cancer care 23 November 2022 Research How companies perform on ensuring access to their SRHR-related products for women and girls in LMICs 25 November 2022 2022 Ranking GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking. Read more Featured Event From insulin to glucose self-monitoring devices: ramping up access along the diabetes continuum of care 15 June 2023 Media Poor countries desperately need better access to generic medicines 15 February 2023 News Joint roundtable with Chatham House identifies key opportunities for expanding access to medical oxygen 12 December 2022 Achievements so far Read more about the Foundation's impact Event Closing the gaps in access to diabetes care in low- and middle-income countries 07 July 2022 News Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries 16 June 2021